FDA Approved: SUMATRIPTAN SUCCINATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Mylan's original application for sumatriptan succinate, a generic product for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan succinate (Sumatriptan succinate)

Snippet

ORIG AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)